EXO1 and cancer: Recently, Chen et al. 28 also conducted a meta-analysis encompassing three polymorphisms in EXO1 and cancer risk, and they concluded that rs9350 polymorphism was a protective factor against cancer, while the rs1047840 polymorphism may be a risk factor.